Short Interest in Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Grows By 200.0%

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) was the target of a significant growth in short interest in July. As of July 15th, there was short interest totalling 1,200 shares, a growth of 200.0% from the June 30th total of 400 shares. Based on an average daily trading volume, of 3,700 shares, the days-to-cover ratio is presently 0.3 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Stock Performance

Shares of HROWM stock traded down $0.33 on Friday, reaching $25.72. 46,025 shares of the company’s stock traded hands, compared to its average volume of 4,171. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 12-month low of $22.71 and a 12-month high of $27.72. The business’s 50 day moving average price is $26.47 and its two-hundred day moving average price is $26.21.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 31st. Stockholders of record on Monday, July 15th will be issued a dividend of $0.7422 per share. The ex-dividend date of this dividend is Monday, July 15th. This represents a $2.97 dividend on an annualized basis and a dividend yield of 11.54%.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Company Profile

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.